Efficacy of silicone gel application for reduction of scars after surgical wound healing

Efficacy of silicone gel application for reduction of scars after repair of hypospadias

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017080735551N1

Enrollment

Registered

2017-08-21

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid scar. Hypertrophic scar

Interventions

Intervention 1: Intervention group: Administration of silicone gel ointment on a lesion twice a day for two months. Intervention 2: Control group: Administration of Vaseline ointment on a lesion twice

Treatment - Drugs

Placebo

Intervention group: Administration of silicone gel ointment on a lesion twice a day for two months

Control group: Administration of Vaseline ointment on a lesion twice a day for two months

Eligibility

Sex/Gender

Male

Age

6 Months to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion:Patients undergoing hypospadias repair and referring to the clinic of Namazi Hospital after the surgery after obtaining informed consent. Exclusion: Patients who have an open wound or open wound infection or history of any allergy or skin disease, or the inability to follow the patient and complete the course of treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Height of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: With a ruler and scoring based on the Vancouver scar scale.;Vascularity of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: Observation and evaluation of post-white fill velocity due to pressure and scoring based on the Vancouver scar scale.;Pliability of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: Touch and scoring based on the Vancouver scar scale.;Pigmentation of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: view and scoring based on the Vancouver scar scale.	—

Measure

Time frame

Height of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: With a ruler and scoring based on the Vancouver scar scale.;Vascularity of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: Observation and evaluation of post-white fill velocity due to pressure and scoring based on the Vancouver scar scale.;Pliability of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: Touch and scoring based on the Vancouver scar scale.;Pigmentation of scar. Timepoint: Before intervention and six months after the end of intervention. Method of measurement: view and scoring based on the Vancouver scar scale.

—

Secondary

Measure	Time frame
Skin atrophy. Timepoint: Six months after the end of intervention. Method of measurement: Has or has not.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Iman Shamohammadi

Shiraz university of medical sciences

imanshamohammadi@yahoo.com+98 71 3647 4332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026